Compare Axogen Inc (AXGN) vs Dover Corp (DOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Dover Corp — how do they compare? Axogen Inc trades at $47.92 (market cap $2.67B), while Dover Corp trades at $206.38 (market cap $28.02B). The key difference: Dover Corp is far larger — about 10.5× Axogen Inc's market cap, and Dover Corp pays a 1.01% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | DOV | |
|---|---|---|
Market Cap | $2.67B | $28.02B |
Sector | Technology | Industrials |
52-Week High | $49.67 | $233.31 |
52-Week Low | $14.79 | $161.16 |
Enterprise Value | $2.58B | $29.53B |
Dividend Yield | — | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.67, up 2.45% today, showing strong momentum near resistance at $50. The stock maintains a bullish technical outlook with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, revenue growth remains robust with Q2 2026 sales up 23.1% to $69.7 million and full-year guidance raised to at least $279 million, but profitability challenges persist with negative net margins and recent earnings misses.
Analyst consensus remains strongly bullish with 84% buy ratings and a $54.33 price target, representing 9.4% upside potential. Key investment opportunities include expanding nerve care platform adoption and reimbursement improvements, while risks include ongoing profitability challenges, competitive pressures, and reliance on elective procedure recovery.
Dover Corporation (DOV) trades at $206.66, down 0.86% on the day, with a bearish technical signal but strong fundamental performance. Recent Q2 2026 earnings beat estimates with EPS of $2.74 versus $2.72 expected, and the company raised full-year guidance. The stock shows a net income margin of 13.48% and a P/E ratio of 25.16, with analyst consensus strongly favoring a buy rating. Recent news highlights dividend increases and the acquisition of Cloeren, bolstering growth prospects in manufacturing and AI-related segments.
The outlook for DOV is positive, driven by earnings beats, raised guidance, and strategic acquisitions. Key opportunities include exposure to high-growth areas like data centers and AI cooling, while risks involve execution of recent acquisitions and broader market volatility. With no sell ratings from analysts and a consensus price target of $232.33, the stock presents upside potential, though investors should monitor integration risks and economic conditions affecting the manufacturing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →
